BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7777624)

  • 1. Malignant hyperthermia: a review.
    Golinski M
    Plast Surg Nurs; 1995; 15(1):30-3, 58. PubMed ID: 7777624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant hyperthermia: a review.
    Johnson C; Edleman KJ
    J Perinatol; 1992 Mar; 12(1):61-71. PubMed ID: 1560293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malignant hyperthermia--diagnostics, treatment and anaesthetic management].
    Schuster F; Müller-Reible CR
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Nov; 44(11-12):758-63; quiz 764. PubMed ID: 19918708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant hyperthermia: current perspectives.
    Felice-Johnson J; Sudds T; Bennett G
    Am J Hosp Pharm; 1981 May; 38(5):646-51. PubMed ID: 7282692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
    McCarthy TV; Quane KA; Lynch PJ
    Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biology of malignant hyperthermia: a disease of the calcium channels of the skeletal muscle].
    Monnier N; Lunardi J
    Ann Biol Clin (Paris); 2000; 58(2):147-56. PubMed ID: 10760701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular calcium homeostasis in human primary muscle cells from malignant hyperthermia-susceptible and normal individuals. Effect Of overexpression of recombinant wild-type and Arg163Cys mutated ryanodine receptors.
    Censier K; Urwyler A; Zorzato F; Treves S
    J Clin Invest; 1998 Mar; 101(6):1233-42. PubMed ID: 9502764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Malignant hyperthermia].
    Schulte-Sasse U; Eberlein HJ
    Anaesthesist; 1983 Apr; 32(4):141-57. PubMed ID: 6349413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant hyperthermia: an OR emergency!
    Plast Surg Nurs; 2000; 20(4):222-6. PubMed ID: 12025057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current understanding of malignant hyperthermia: genesis, prevention, and treatment.
    Katz DN
    CRNA; 1992 May; 3(2):54-63. PubMed ID: 1483145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Malignant hyperthermia].
    Glahn KP
    Ugeskr Laeger; 2003 Apr; 165(17):1763-8. PubMed ID: 12768904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant hyperthermia: pathophysiology, clinical presentation, and treatment.
    McCarthy EJ
    AACN Clin Issues; 2004; 15(2):231-7. PubMed ID: 15461040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and localization of mutations in the 106 exons of the RYR1 gene in 50 individuals with malignant hyperthermia.
    Galli L; Orrico A; Lorenzini S; Censini S; Falciani M; Covacci A; Tegazzin V; Sorrentino V
    Hum Mutat; 2006 Aug; 27(8):830. PubMed ID: 16835904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suspected malignant hyperthermia in a child with laminin alpha2 (merosin) deficiency in the absence of a triggering agent.
    Shukry M; Guruli ZV; Ramadhyani U
    Paediatr Anaesth; 2006 Apr; 16(4):462-5. PubMed ID: 16618304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and biochemical characterization of a novel ryanodine receptor gene mutation associated with malignant hyperthermia.
    Anderson AA; Brown RL; Polster B; Pollock N; Stowell KM
    Anesthesiology; 2008 Feb; 108(2):208-15. PubMed ID: 18212565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel ryanodine receptor mutation that may cause malignant hyperthermia.
    Kaufmann A; Kraft B; Michalek-Sauberer A; Weigl LG
    Anesthesiology; 2008 Sep; 109(3):457-64. PubMed ID: 18719443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignant hyperthermia--a hereditary and potentially life-threatening condition].
    Haugen T; Toft M; Müller CR; Aasly J
    Tidsskr Nor Laegeforen; 2005 Oct; 125(20):2792-4. PubMed ID: 16244682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anesthetic malignant hyperthermia: what's new in 2012?].
    Nivoche Y; Bruneau B; Dahmani S
    Ann Fr Anesth Reanim; 2013 Jan; 32(1):e43-7. PubMed ID: 23290613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of malignant hyperthermia-associated RyR1 mutations in exon 44, using the human myotube model.
    Wehner M; Rueffert H; Koenig F; Olthoff D
    Neuromuscul Disord; 2004 Jul; 14(7):429-37. PubMed ID: 15210166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing the number of diagnostic mutations in malignant hyperthermia.
    Levano S; Vukcevic M; Singer M; Matter A; Treves S; Urwyler A; Girard T
    Hum Mutat; 2009 Apr; 30(4):590-8. PubMed ID: 19191329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.